Angiogenesis factor in endometrial carcinoma: a new prognostic indicator?

Area of Science:

• Oncology
• Pathology
• Cancer Research

Background:

• Tumor angiogenesis is a key factor in cancer progression, influencing tumor growth, metastasis, and recurrence.
• Previous studies in various cancers (breast, prostate, lung, melanoma) link neovascularization to poorer prognoses.
• Endometrial cancer prognosis requires further investigation into prognostic indicators like microvessel density.

Purpose of the Study:

• To evaluate microvessel density as a prognostic factor in endometrial cancer.
• To determine the correlation between microvessel density and patient survival.
• To assess the relationship between microvessel density and disease recurrence in endometrial cancer.

Main Methods:

• Retrospective analysis of 50 endometrial cancer patients (25 recurrent, 25 non-recurrent) diagnosed between 1980-1991.
• Histologic review of tumor tissue, focusing on the deepest myometrial invasion.
• Immunocytochemical staining for factor VIII-related antigen to highlight microvessels, counted by blinded investigators.

Main Results:

• Microvessel density showed a trend towards correlating with recurrence likelihood, though not statistically significant.
• Patients with low microvessel density had a mean survival of 123 months, versus 75 months for high microvessel density (p=0.02).
• In recurrent cases, low microvessel density correlated with 64 months mean survival, compared to 45 months for high microvessel density (p=0.002).

Conclusions:

• Microvessel density is a significant prognostic factor in endometrial carcinoma.
• Increased angiogenesis, indicated by higher microvessel density, is associated with poorer survival outcomes.
• Angiogenesis correlates with survival in endometrial cancer, suggesting its role in disease progression.